Mr. Darshan Udani Pharmacist-In-Charge

With over 9 years experience in sterile compounding and pharmaceutical manufacturing. Mr. Udani specializes in facility design, aseptic processing, and Current Good Manufacturing Practices (cGMP) operations. He previously directed pharmacy operations at a regional hospital system, where he spearheaded initiatives to streamline drug shortage management and reduce preparation errors. Highly effective in providing disease state education, searching, and evaluating scientific literature, and performing drug utilization reviews to optimize patient care. Effective communicator who can translate difficult medical concepts into comprehensible information.

Mr. Dasaradhi Lakkaraju, PhD Research and Development

Dr. Das got his Ph.D from Osmania university and did his Postdoctoral fellowship in the Department of Chemistry at University of Durham in England, New Mexico State University, and at the Department of Pharmacology in State University of New York, Stony Brook. Dr. Das brings a tremendous amount of knowledge that was built over 24 years of analytical chemistry experience in the pharmaceutical industry. He has experience in solid orals, both extended release and immediate release tablets, and capsule formulations including controlled substances, as well as parenteral: lyophilized products and liquids, oil based depot formulations, suspensions, peptides, steroids and oncology products, ophthalmic: liquids and suspensions. He has lead intellectual property development projects using reverse engineering techniques and circumventing patents for Paragraph-IV filings. He has contributed significantly to several ANDAS, NDAs and 505(b)(2)s. He has published 24 papers in peer reviewed Journals and also has patents in formulation development.

Mr. Nirav Patel, Ph.D., CChem, FRSC Vice President-Research and Development

A pharmaceutical visionary with over 22 years of experience in healthcare and drug development. As Vice President of Research & Development at Nivagen Pharmaceuticals, he leads formulation R&D, process development, and regulatory strategy for complex injectable and ophthalmic products. Prior to Nivagen, he held leadership roles at Amneal, Ingenus, Jubilant, Symbiotec, and Baxter. A recognized expert in Quality by Design (QbD), novel drug delivery systems, and sterile injectables, Dr. Patel has successfully launched numerous branded, generic, and 503B compounded products. He is the author of multiple scientific publications and patents and has been honored as a Fellow of the Royal Society of Chemistry (FRSC) and Chartered Chemist (CChem).

Mr. Scott Bobbitt Vice President-Quality

With more than 25 years of experience in pharmaceutical quality, manufacturing, and compliance, Mr. Scott has built a distinguished career leading quality organizations across the biotechnology and pharmaceutical industries. His expertise spans GMP operations, quality systems, regulatory compliance, inspection readiness, and the commercialization of complex pharmaceutical and biologic products. Throughout his career, he has held senior leadership roles at leading life sciences organizations, driving operational excellence, strengthening quality cultures, and ensuring the highest standards of product quality and patient safety.

Mrs. Heather Craig Regional Sales Director

A results-driven sales and operations leader with over 15 years of experience across healthcare, wellness, medical aesthetics, and pharmaceutical industries. Expertise includes business development, strategic partnerships, team leadership, territory expansion, and revenue growth. Currently supporting the growth of Nivagen Pharmaceuticals’ 503B outsourcing pharmacy operations, with a focus on expanding provider access to compliant compounded sterile preparations and wellness therapies. Skilled in CRM-driven sales management, KPI tracking, and building long-term client relationships through a consultative, education-focused approach.